文献速递肝病消化道肿瘤与早癌

DNA甲基化特征揭示肝细胞癌甲基化组重塑过程的多样性

DNA Methylation Signatures Reveal the Diversity of Processes Remodeling Hepatocellular Carcinoma Methylomes.
PubMed 文献 · Hepatology · 2021-01-01

该研究开发了MethICA计算框架,利用独立成分分析解析肿瘤DNA甲基化变化中混杂的多种过程。应用于738例肝细胞癌,识别出13个稳定的甲基化成分,这些成分优先活跃于特定染色质状态、序列背景和复制时序,包括与性别、年龄相关的一般过程特征以及与特定驱动事件和分子亚组相关的特征。研究阐明了重塑肝细胞癌甲基化组的多种过程,并揭示了驱动基因改变的 epigenet ic 和转录影响。

要点

  • MethICA框架可解析肝细胞癌甲基化组中混杂的多种生物学过程
  • CTNNB1突变导致Wnt靶基因附近TCF7结合增强子靶向低甲基化及晚期复制部分甲基化域广泛低甲基化
  • 复 制应激特征为早期复制高甲基化域去甲基化,在细胞周期蛋白激活的肝细胞癌中导致广泛低甲基化表型

核心结论

  • 本研究阐明了重塑肝细胞癌甲基化组的多种过程,并揭示了驱动基因改变的表观遗传和转录影响。

研究设计与样本

  • 开发了MethICA计算框架,利用独立成分分析解析肿瘤DNA甲基化变化中的多种过程,并应用于738例肝细胞癌样本。

主要发现

  • MethICA识别出13个稳定的甲基化成分,优先活跃于特定染色质状态、序列背景和复制时序。
  • CTNNB1突变是肝细胞癌甲基化模式的主要调节因素,特征为Wnt靶基因附近TCF7结合增强子的靶向低甲基化以及晚期复制部分甲基化域的广泛低甲基化。
  • 早期复制高甲基化域的去甲基化是复制应激的特征,在细胞周期蛋白激活的肝细胞癌中导致广泛低甲基化表型。
  • ARID1A失活突变与分化促进转录网络的表观遗传沉默相关,在肝硬化肝脏中也可检测到。
  • 在具有祖细胞特征的G1分子亚组中识别出靶向多梳抑制染色质域的高甲基化特征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: DNA methylation patterns are highly rearranged in HCCs. However, diverse sources of variation are intermingled in cancer methylomes, precluding the precise characterization of underlying molecular mechanisms. We developed a computational framework (methylation signature analysis with independent component analysis [MethICA]) leveraging independent component analysis to disentangle the diverse processes contributing to DNA methylation changes in tumors. APPROACH AND RESULTS: Applied to a collection of 738 HCCs, MethICA unraveled 13 stable methylation components preferentially active in specific chromatin states, sequence contexts, and replication timings. These included signatures of general processes associated with sex and age but also signatures related to specific driver events and molecular subgroups. Catenin beta 1 mutations were major modulators of methylation patterns in HCC, characterized by a targeted hypomethylation of transcription factor 7-bound enhancers in the vicinity of Wnt target genes as well as a widespread hypomethylation of late-replicated partially methylated domains. By contrast, demethylation of early replicated highly methylated domains was a signature of replication stress, leading to an extensive hypomethylator phenotype in cyclin-activated HCC. Inactivating mutations of the chromatin remodeler AT-rich interactive domain-containing protein 1A were associated with epigenetic silencing of differentiation-promoting transcriptional networks, also detectable in cirrhotic liver. Finally, a hypermethylation signature targeting polycomb-repressed chromatin domains was identified in the G1 molecular subgroup with progenitor features. CONCLUSIONS: This study elucidates the diversity of processes remodeling HCC methylomes and reveals the epigenetic and transcriptional impact of driver alterations.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Meunier L, Hirsch TZ, Caruso S, et al. DNA Methylation Signatures Reveal the Diversity of Processes Remodeling Hepatocellular Carcinoma Methylomes. Hepatology. 2021. PMID: 33713365. doi:10.1002/hep.31796

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。